Search
for
Sort by
Research 181–210 of 1000+
- Antinuclear Antibody Positivity in Patients With Hair Loss After COVID-19 Infection
- COVID-19: The question of genetic diversity and therapeutic intervention approaches
- Telogen effluvium after COVID-19 vaccination among public in Saudi Arabia
- Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
- Unraveling Dermatological Manifestations after COVID-19: Insights from Skin Pigmentation and Hair Loss Patterns
- Dermatolojik Problemler ve COVID-19
- Eflúvio telógeno pós-infecção por Covid-19: uma revisão narrativa / Telogen effluvium post Covid-19 infection: a narrative review
- Understanding sex and gender disparities in COVID-19 mortality: a narrative review beyond biology
- Manifestações dermatológicas durante e após a COVID-19: Uma revisão narrativa / Dermatological manifestations during and after Covid-19: A narrative review
- 26021 Delivering care for the underserved during COVID-19 through real-time teledermatology, a cross-sectional review of patients at a student-run free clinic in Dallas
- Roles of steroid receptors in the lung and COVID-19
- Bioavailability Enhancement of Cepharanthine via Pulmonary Administration in Rats and Its Therapeutic Potential for Pulmonary Fibrosis Associated with COVID-19 Infection
- Unraveling the mechanism of action of cepharanthine for the treatment of novel coronavirus pneumonia (COVID-19) from the perspectives of systematic pharmacology
- In response to the letter to the editor by Soha Ghanian et al. re our publication “Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males”
- Telogen effluvium: a 360 degree review
- Telogen effluvium in the new SARS‐CoV‐2 era
- The changing landscape of managing hair loss: a 30‐year perspective
- SARS-CoV-2 Infection—A Trigger Factor for Telogen Effluvium: Review of the Literature with a Case-Based Guidance for Clinical Evaluation
- Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection: Insight into the pathophysiology with implication for better management
- Comment on: The Gabrin sign
- Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection
- Medication-induced hair loss: An update
- A Study of the Clinical Patterns of Hair Loss in Female Patients
- Global Epidemiology of Telogen Effluvium after COVID-19 Pandemic: A Systematic Review and Modeling Study
- The Experience of SARS-CoV-2 in Patients with Benign Prostatic Hyperplasia: Is There Any Correlation between Them?
- Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium
- Hormonal trends in patients suffering from long COVID symptoms
- Trend and Co-occurrence Network of COVID-19 Symptoms From Large-Scale Social Media Data: Infoveillance Study
- COVID-19 Can Exacerbate Pattern Hair Loss and Trigger Telogen Effluvium - The Role of Proteoglycan Replacement Therapy with Nourkrin® in Clinical Treatment of COVID-19 Associated Hair Loss
- A Case of Telogen Effluvium as COVID Sequelae